Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sickle Cell Disease
92%
Pediatric
40%
NADPH Oxidase
37%
Hematopoietic Stem Cells
37%
Chronic Granulomatous Disease
32%
Neutrophils
31%
Hematopoietic Cell Transplantation
30%
Tumor
25%
Acute Myeloid Leukemia
25%
Gp91phox
23%
Neurofibromatosis Type 1 (NF-1)
22%
Von Willebrand Disease
21%
Von Willebrand Factor
21%
X-linked Chronic Granulomatous Disease (X-CGD)
21%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
GATA4
20%
Platelets
19%
Survivors
19%
Older Adults
18%
Chronic Graft-versus-host Disease (cGVHD)
18%
Transcription Factor
18%
Pediatric Patients
18%
Low-density Lipoprotein Receptor
18%
Sickle Cell Anemia
18%
Asialoglycoprotein Receptor (ASGPR)
17%
Graft-versus-host Disease (GvHD)
17%
Neurofibromatosis Type I
17%
Glioblastoma
16%
Ubiquitin
16%
Pediatric Oncology
15%
Stem Cell Transplantation
15%
95% Confidence Interval
15%
Cell Surface
14%
Transplantation
14%
Overall Survival
13%
Hematopoietic Stem Cell Transplantation
13%
Medulloblastoma
13%
Chemotherapy
13%
Thrombosis
13%
Mouse Model
12%
Clinical Trials
12%
Oxidase
12%
High Risk
12%
Glioma
12%
Brain Tumor
12%
Macrophages
12%
Oncology
12%
Sex Differences
11%
Phagocytes
11%
Leukemia
11%
Hepatoma Cells
10%
Odds Ratio
10%
Inflammation
10%
Endocytosis
10%
Hematopoietic Stem Cell Transplant
10%
Hydroxyurea
10%
Reduced-intensity Conditioning
10%
Lipoprotein Receptors
10%
Transfusion
10%
Children's Oncology Group
10%
In Cancer
10%
Late Effects
10%
NADPH Oxidase 4 (NOX4)
10%
Caregivers
9%
Central Nervous System
9%
P22phox
9%
Granulocyte Colony-stimulating Factor (G-CSF)
9%
Childhood Cancer Survivors
9%
United States
9%
Rac2
9%
Bone Marrow
9%
Radiation Therapy
9%
Superoxide Production
9%
Gene Therapy
9%
Superoxide
9%
Hemostasis
9%
GATA6
9%
C-X-C Chemokine Receptor Type 4 (CXCR4)
9%
Hemophilia
9%
Risk Factors
9%
Gene Expression
9%
DNA Double-strand Breaks
9%
Engraftment
9%
Ubiquitin System
9%
Bleeding
8%
B Cells
8%
Vascular Anomalies
8%
P47phox
8%
Event-free Survival
8%
Tumor Cells
8%
Wilms Tumor
8%
X-linked
8%
Receptor-mediated Endocytosis
8%
Myelodysplastic Syndrome
8%
HepG2 Cells
8%
Gene Transfer
8%
Flavocytochrome
8%
Quality of Life
8%
NCCN Guidelines
8%
Low Von Willebrand Factor
8%
Medicine and Dentistry
Sickle-Cell Disease
100%
Pediatrics
77%
Diseases
47%
Malignant Neoplasm
42%
Adolescence
38%
Hematopoietic Cell
35%
Childhood Cancer
28%
Oncology
28%
Chemotherapy
25%
Ganglioglioma
25%
Cell Transplantation
24%
Neoplasm
22%
Genetics
21%
Pediatrics Patient
20%
Hematopoietic Stem Cell Transplantation
19%
Thrombosis
16%
Tumor
16%
Von Willebrand Disease
16%
Overall Survival
16%
Neurofibromatosis Type I
16%
Von Willebrand Factor
16%
Clinician
16%
Platelet
16%
Education
16%
Transcription Factor GATA 4
15%
Quality of Life
14%
Radiation Therapy
13%
Apoplexy
13%
Hydroxyurea
13%
Medulloblastoma
12%
Odds Ratio
12%
Clinical Trial
12%
Bleeding
11%
Graft Versus Host Reaction
11%
Sickle Cell
11%
Prevalence
11%
Cancer
11%
Pediatric Cancer
11%
Magnetic Resonance Imaging
10%
Late Effect
9%
Event Free Survival
9%
Acute Lymphoblastic Leukemia
9%
Patient with Sickle Cell Disease
8%
Intracranial Tumor
8%
Systematic Review
8%
Central Nervous System
8%
Blood Transfusion
8%
Engraftment
8%
Reduced Intensity Conditioning
8%
Blood Stasis
8%
Cell Therapy
8%
Brain Infarction
7%
Germinoma
7%
Infection
7%
Morbidity
7%
Central Nervous System Tumor
7%
Chronic Granulomatous Disease
7%
Stem Cell Therapy
7%
Myelodysplastic Syndrome
7%
Leukemia
7%
Sex Differences
7%
Stem Cell Transplant
7%
Acute Myeloid Leukemia
6%
Wilms' Tumor
6%
Atypical Teratoid Rhabdoid Tumor
6%
Decision Making
6%
Thrombocytopenia
6%
Cord Blood
6%
Allograft
6%
Posttransplant Lymphoproliferative Disease
6%
Recurrent Disease
6%
Emergency Department
6%
Transcription Factor GATA 6
6%
Acute Leukemia
6%
Adverse Event
5%
Vascular Anomaly
5%
T Cell
5%
Solid Malignant Neoplasm
5%
Cancer Therapy
5%
Pediatric Brain Tumor
5%
Haemophilia A
5%
Infarction
5%
Neutrophil
5%
Hemoglobins
5%
Plexiform Neurofibroma
5%
Receptor
5%
Ganglioneuroblastoma
5%
Pilocytic Astrocytoma
5%
Gene Expression
5%
Survival Rate
5%
Biochemistry, Genetics and Molecular Biology
Ubiquitin
38%
Myeloid
35%
NAD(P)H Oxidase
35%
Hematopoietic Cell
31%
Oxidoreductase
26%
Genetics
25%
Oxidase
24%
Platelet
19%
Deficiency
19%
Phagocyte
19%
Gene Expression
17%
Von Willebrand Factor
17%
Pediatrics
16%
LDL Receptor
16%
Wild Type
16%
GATA4
16%
Enzyme
14%
N-Terminus
14%
Endocytosis
14%
Transcription Factors
14%
Carcinogenesis
13%
Lipoprotein Receptor-Related Protein
13%
Ubiquitin-Conjugating Enzyme
12%
Proteasome
12%
Promoter Region
12%
B Cell
11%
Signal Transduction
11%
Genomics
10%
Blood Plasma
10%
Sex Differences
9%
Ubiquitination
9%
Double-Strand DNA Break
9%
Von Willebrand Disease
9%
Kinase
9%
Phosphotransferase
9%
Asialoglycoprotein Receptor
9%
RNA
8%
Programmed Cell Death
8%
phosphorylation
8%
C-Terminus
8%
Maturation
8%
Metabolic Pathway
8%
Nicotinamide Adenine Dinucleotide Phosphate
8%
Germ Cell
8%
Tumor Suppressor Protein
8%
Stem Cell
8%
Messenger RNA
8%
Transcription
7%
Allele
7%
Cyclic Adenosine Monophosphate
7%
Precursor
7%
Mouse Model
7%
Nucleotide
7%
Germline
7%
P53
7%
P22phox
7%
Cancer Cell
7%
Amino Acids
7%
Haemophilia A
7%
Cell Cycle
7%
Cell Function
7%
Factor VIII
6%
Isoform
6%
DNA Damage Response
6%
Subcellular Localization
6%
Adenosine Triphosphate
6%
Enhancer Region
6%
Tumor Progression
6%
MyoD
6%
Non-Homologous End Joining
6%
RNA Sequence
6%
Anabolism
6%
Cell Survival
6%
Ligand Binding
5%
DNA Methylation
5%
Dyskeratosis Congenita
5%
Cytochrome B
5%
Cell Membrane
5%
Iodine-125
5%
Homologous Recombination
5%
Cytochrome
5%
Cell Proliferation
5%
Hematopoiesis
5%
Cell Migration
5%
Protein Biosynthesis
5%
Macrophage
5%
Plasminogen Activator
5%
Gene Mutation
5%
Gene Therapy
5%
Tissue Factor Pathway Inhibitor
5%
Sonic Hedgehog
5%
Rat
5%